Takara Bio Inc.

TSE:4974.T

1018 (JPY) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 43,50578,14267,69946,08634,56535,84132,31229,37529,72925,96923,90520,56419,57818,73719,32518,91320,27820,98216,53413,685
Cost of Revenue 18,04833,37718,48814,21413,45915,15513,65712,42213,40512,14211,3319,5409,1948,8589,2868,97310,05511,1609,3757,317
Gross Profit 25,45744,76549,21131,87221,10620,68618,65516,95316,32413,82712,57411,02410,3849,87910,0399,94010,2239,8227,1596,368
Gross Profit Ratio 0.5850.5730.7270.6920.6110.5770.5770.5770.5490.5320.5260.5360.530.5270.5190.5260.5040.4680.4330.465
Reseach & Development Expenses 6,8738,5756,1095,5453,8694,3374,6534,1014,2753,4013,0262,7152,6582,6923,2942,9763,2963,2393,1212,987
General & Administrative Expenses 000000000000687211210295000
Selling & Marketing Expenses 000007037298549719039859639419629691,1491,1151,3361,6431,277
SG&A 15,58115,64914,20012,37410,9617037298549719039859631,0091,0341,0811,2511,2101,3361,6431,277
Other Expenses 14314416611610014124231446633918918921912915098156242197158
Operating Expenses 22,45424,21920,30717,91714,82715,21815,09613,74813,65211,52210,6169,3275,6125,7006,2766,1816,5856,8466,1185,362
Operating Income 3,00320,54128,90213,9526,2745,4633,5553,2022,6672,3021,9541,6914,7724,1793,7633,7593,6382,9761,0411,006
Operating Income Ratio 0.0690.2630.4270.3030.1820.1520.110.1090.090.0890.0820.0820.2440.2230.1950.1990.1790.1420.0630.074
Total Other Income Expenses Net -150682-1,371-401-845-644-198-399234176227571-3,110-3,201-3,066-3,660-2,967-2,601-2,293-1,894
Income Before Tax 2,85321,22427,53213,5525,4334,8233,3612,8052,9052,4812,1852,2681,66297869799671375-1,252-888
Income Before Tax Ratio 0.0660.2720.4070.2940.1570.1350.1040.0950.0980.0960.0910.110.0850.0520.0360.0050.0330.018-0.076-0.065
Income Tax Expense 1,3435,1767,6243,9711,6011,1491,0231,4491,5651,521726809631361107-545-1792-149444
Net Income 1,48016,01219,8499,5473,8193,6572,3351,3521,3349631,4701,4621,023605591642679320-1,058-1,282
Net Income Ratio 0.0340.2050.2930.2070.110.1020.0720.0460.0450.0370.0610.0710.0520.0320.0310.0340.0330.015-0.064-0.094
EPS 12.29132.97164.8479.2831.7230.3719.3911.2411.088.0112.512.949.065.375.245.76.032.86-9.94-13.7
EPS Diluted 12.29132.97164.8479.2831.7230.3719.3911.2411.088.0112.4512.899.065.375.235.685.982.86-9.94-13.7
EBITDA 8,02425,44132,62917,9689,8799,6837,0985,6295,3694,4553,7143,4826,6026,0305,9325,7666,1165,7494,3002,848
EBITDA Ratio 0.1840.3260.4820.390.2860.270.220.1920.1810.1720.1550.1690.3370.3220.3070.3050.3020.2740.260.208